Related Experiment Video
Updated: Apr 16, 2026

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
Circulating endothelial cells in coronary artery disease and acute coronary syndrome
David E Schmidt1, Marco Manca2, Imo E Hoefer3
1University Medical Center Utrecht, Maastricht, The Netherlands.
Insights
Circulating endothelial cells (CECs) show promise as biomarkers for cardiovascular diseases. Further research into improved counting methods and large-scale studies is needed to confirm their clinical value.
Area of Science:
- Cardiovascular Research
- Biomarker Discovery
- Cellular Biology
Background:
- Circulating endothelial cells (CECs) are recognized as potential biomarkers for diagnosing and predicting coronary artery disease and acute coronary syndromes.
- Understanding the physiology and pathobiology of CECs, including their interactions with endothelial progenitor cells and microparticles, is crucial.
Purpose of the Study:
- To review current knowledge on CECs as cardiovascular biomarkers.
- To explore advancements in CEC quantification, morphology, transcriptomics, and proteomics for improved diagnostic and prognostic value.
- To highlight the need for standardized methods and further research.
Main Methods:
- Comprehensive literature review of studies on circulating endothelial cells.
- Analysis of current insights into CEC physiology, pathobiology, and quantification methods.
- Evaluation of emerging techniques for CEC characterization.
Main Results:
- CECs hold significant potential as diagnostic and prognostic indicators for cardiovascular conditions.
- Current quantification methods require improvement and a consensus on cell definition is lacking.
- Integrating CEC morphology, transcriptomics, and proteomics may enhance their utility.
Conclusions:
- Standardized counting methods and a validated CEC definition are essential for clinical application.
- Large-scale, population-based prospective studies are necessary to establish the definitive clinical value of CECs in cardiovascular medicine.
Abstract:
Circulating endothelial cells (CECs) have been put forward as a promising biomarker for diagnosis and prognosis of coronary artery disease and acute coronary syndromes. This review entails current insights into the physiology and pathobiology of CECs, including their relationship with circulating endothelial progenitor cells and endothelial microparticles. Additionally, we present a comprehensive overview of the diagnostic and prognostic value of CEC quantification, as well as possibilities for improvement, for example, by inclusion of CEC morphology, transcriptomics, and proteomics. The current stand of knowledge calls out for improved counting methods and consensus on a validated cell definition. Finally, our review accentuates the importance of large, well-designed, population-based prospective studies that will have to show the clinical value of CEC as a cardiovascular biomarker.
More Related Videos
10:03Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
08:43Isolation of Endothelial Progenitor Cells from Healthy Volunteers and Their Migratory Potential Influenced by Serum Samples After Cardiac Surgery
Published on: February 14, 2017
Related Concept Videos
Coronary Artery Disease II: Pathophysiology
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Regulation of Angiogenesis and Blood Supply
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies